Doximity filings document financial results, material events, governance actions, and capital-structure details for the operator of a digital platform for U.S. medical professionals. Recent Form 8-K disclosures cover quarterly results and related exhibits, finance and legal leadership changes, Regulation FD updates, and annual-meeting voting outcomes.
The company's regulatory record also includes shareholder voting matters tied to its Class A and Class B common stock structure, director elections, auditor ratification, material agreements, and other security-holder matters. These filings describe how Doximity reports operating performance, governance changes, voting mechanics, and formal public-company events.
DOCS filed a Form 144 disclosing an intended sale of 9,000 shares of Common stock via a Stock Option Exercise on 05/07/2026 for cash. The filing records a prior sale of 2,000 shares by Kira Wampler on 03/03/2026 for $52,000.
Doximity Inc ownership filing: Vanguard Capital Management reports beneficial ownership of 6,785,531 shares of common stock, representing 5.07% of the class as reported in the Schedule 13G. The filing shows sole dispositive power over 6,785,531 shares and sole voting power over 1,020,468 shares. The report notes these holdings reflect securities held for Vanguard funds and managed accounts and attributes voting/dispositive powers across Vanguard affiliates.
Doximity, Inc. announced that Chief Financial Officer Anna Bryson, who had been on medical leave since early February 2026, resigned from her role effective April 13, 2026. Chief Accounting Officer Siddharth Sitaram continues to serve as interim principal financial and accounting officer until a new CFO is appointed.
The company plans to give an update on its CFO search during its next earnings call. Doximity also reaffirmed its previously issued guidance for the fourth quarter and full fiscal year ending March 31, 2026, as first shared on February 5, 2026.
Doximity interim PFO and PAO Siddharth Sitaram exercised and converted derivative awards and sold a portion of shares in connection with taxes. On April 10, 2026, he exercised a stock option for 5,000 shares at $4.12 per share and converted 5,000 Class B into 5,000 Class A shares.
He then sold 2,427 Class A Common Stock at $21.09 per share in a sell-to-cover transaction to satisfy tax withholding obligations under a pre-arranged Rule 10b5-1 trading plan. Following these transactions, he directly held 86,705 shares of Class A Common Stock and 78,800 option shares.
The filing reports proposed sales of Common stock under a Form 144 by an affiliate, with a trade date of 04/10/2026 tied to a stock option exercise handled by Morgan Stanley Smith Barney LLC. The excerpt lists three completed dispositions in the prior three months (2324, 2319, 2282 shares) with associated cash amounts and an indicated sale method of Cash.
The Vanguard Group amended its Schedule 13G to report zero shares beneficially owned of Doximity Inc. The filing states that on January 12, 2026 The Vanguard Group, Inc. underwent an internal realignment and certain subsidiaries will report beneficial ownership separately in reliance on SEC Release No. 34-39538.
The amendment lists 0 shares beneficially owned and 0% of the class, and explains that Vanguard no longer is deemed to beneficially own shares held by those reorganized subsidiaries.
Doximity, Inc. interim PFO and PAO Siddharth Sitaram exercised stock options for 5,000 shares of Class B Common Stock at an exercise price of $4.12 per share, which converted into 5,000 shares of Class A Common Stock at his option.
He then sold 2,319 shares of Class A Common Stock at $25.37 per share in an automatic sell-to-cover transaction under a Rule 10b5-1 trading plan to satisfy tax withholding obligations. Following these transactions, he directly holds 84,132 shares of Class A Common Stock.
Doximity, Inc. interim PFO and PAO Siddharth Sitaram exercised stock options and converted Class B shares into Class A shares, then sold a small portion of stock. He exercised options for 5,000 shares at an exercise price of $4.12 per share and converted 5,000 shares of Class B Common Stock into 5,000 shares of Class A Common Stock.
He then sold 2,282 shares of Class A Common Stock at $27.88 per share in an open-market transaction executed automatically under a Rule 10b5-1 trading plan and described as a sell-to-cover for tax withholding. Following these transactions, he directly held 81,451 shares of Class A Common Stock.
DOCS Rule 144 notice: Morgan Stanley Smith Barney LLC reported a proposed sale of 2,319 Common shares via a stock option exercise for cash on 03/10/2026. The filing lists prior dispositions of 2,282 shares on 02/10/2026 and 2,324 shares on 01/12/2026.
Doximity, Inc. director Kira Scherer Wampler reported several related equity transactions. On March 3, 2026, she exercised a stock option for 2,000 shares at a price of $0.0000 per share, increasing her direct option-related holdings to 456,700 shares as of that date.
On the same date, 2,000 shares of Class B Common Stock converted into 2,000 shares of Class A Common Stock at a conversion price of $0.0000 per share, and the Class B position from this lot went to 0 shares. After this conversion, her direct Class A holdings were 21,839 shares.
Also on March 3, 2026, Wampler completed an open-market sale of 2,000 shares of Class A Common Stock at a price of $26.0000 per share, leaving her with 19,839 shares of Class A Common Stock held directly. According to a footnote, these sales occurred automatically under a Rule 10b5-1 trading plan adopted on November 12, 2024, indicating they were pre-scheduled rather than discretionary trades.